VivoSeq
Other

Emotional Processing

0

Pipeline Programs

2

Active Trials

1

Companies Involved

Emotional Processing is an early-stage landscape with 0 programs across 1 company. The most active players are GSK.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

16

clinical trials

Completed13 · 81%
Recruiting2 · 13%
Unknown status1 · 6%

Trial Activity

16 trials

Losartan and Emotional Processing in Young People
Recruiting·UUniversity of Oxford·Phase 1·NCT06636812·60 enrolled
Pramipexole and Emotional Processing
Completed·UUniversity of Oxford·N/A·NCT03681509·43 enrolled
Simvastatin and Emotional Processing (OxSTEP)
Completed·UUniversity of Oxford·N/A·NCT04973800·101 enrolled
7-day Atorvastatin and Emotional Processing
Completed·UUniversity of Oxford·N/A·NCT03966859·50 enrolled
7-day Simvastatin and Emotional Processing
Completed·UUniversity of Oxford·Phase 1/2·NCT04652089·53 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)